Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations
Clinical trial NCT04688008 · COMPLETED
Trial details
- NCT number
- NCT04688008
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2020-10-12
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.